Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot ambulatory cortisol monitoring in depression and PTSD with dexamethasone and mifepristone challenge
NL-OMON56993Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dexamethasone and mifepristone in major depressive disorder (MDD) and post-traumatic stress disorder (PTSD), sponsored by Amsterdam University Medical Center. Started Nov 2025; status: active, not recruiting.
02
Drugs
dexamethasonemifepristone
03
Conditions
major depressive disorder (MDD)post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NL-OMON56993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56993.